Compare BCH & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCH | BNTX |
|---|---|---|
| Founded | 1893 | 2008 |
| Country | Chile | Germany |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.3B | 24.2B |
| IPO Year | 2002 | 2019 |
| Metric | BCH | BNTX |
|---|---|---|
| Price | $41.53 | $100.51 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 13 |
| Target Price | $36.00 | ★ $133.46 |
| AVG Volume (30 Days) | 265.8K | ★ 1.6M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.52% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $24.84 | N/A |
| Revenue Next Year | $6.49 | $3.37 |
| P/E Ratio | $16.27 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.95 | $79.81 |
| 52 Week High | $46.77 | $124.00 |
| Indicator | BCH | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 48.70 | 50.50 |
| Support Level | $39.34 | $87.58 |
| Resistance Level | $41.63 | $104.05 |
| Average True Range (ATR) | 0.84 | 3.95 |
| MACD | -0.10 | -0.44 |
| Stochastic Oscillator | 41.86 | 35.73 |
Operating under three separate brand names (Banco de Chile, Banco Edwards-Citi, and Banco CrediChile), Banco de Chile is the second largest in the country by loans and third largest by deposits. Banco de Chile generates most of its net interest income (roughly 60% of total revenue) from its mortgage, unsecured consumer credit lines, and commercial loans, with 25% of its outstanding loans being made to firms with more than 10,000 million CLP in revenue. Outside of its banking business, Banco de Chile is the largest asset manager in the country and one of the largest security brokerages, supporting its substantial fee-based revenue.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.